Shardul Amarchand Mangaldas Advised Nephrocare Health Services Limited On Its Initial Public Offering
Shardul Amarchand Mangaldas advised Nephrocare Health Services Limited on its Initial Public Offering
The leading law firm in India, Shardul Amarchand Mangaldas & Co. (SAM) advised Nephrocare Health Services Limited (“Nephroplus”) on its initial public offering (IPO) aggregating to approximately US$ 95.99 million (₹ 8,710.48 million), comprising a fresh issue of ₹ 3,534.05 million and an offer for sale of ₹ 5,176.43 million.
SAM acted as legal counsel on Indian law aspects of the transaction, advising on drafting and regulatory compliance for the IPO, coordinating with multiple domestic and international stakeholders, and supporting the company through the prospectus filing and listing process.
The SAM team was led by Prashant Gupta (National Practice Head – Capital Markets) and Devi Prasad Patel (Partner), with assistance from Divya Dhawan (Associate), Satakshi N. Dixit (Associate), and Arjun Bhatia (Associate).
Click to know more about Shardul Amarchand Mangaldas
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
